HIGHLIGHTS
- who: Motoi Yamashita et al. from the University, China have published the paper: Case report: HLA-haploidentical hematopoietic cell transplant with posttransplant cyclophosphamide in a patient with leukocyte adhesion deficiency type I, in the Journal: (JOURNAL)
SUMMARY
Ex vivo T-cell depletion techniques, such as Tcell receptor-a/b+ and CD19+ cell depletion and CD34+ cell selection of the grafts, have been used, but these manipulations are highly expensive and require specific equipment. PT-CY has been increasingly used as the strong GVHD prophylactic measures, especially in haploidentical HCT. Although an increasing number . . .

If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.